Literature DB >> 21532561

Autoimmune disease: New drug target for MS?

Alexandra Flemming.   

Abstract

Entities:  

Year:  2011        PMID： 21532561     DOI： 10.1038/nrd3450

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis.

Authors:  Rieko Muramatsu; Takekazu Kubo; Masahiro Mori; Yuka Nakamura; Yuki Fujita; Tsugio Akutsu; Tatsusada Okuno; Junko Taniguchi; Atsushi Kumanogoh; Mari Yoshida; Hideki Mochizuki; Satoshi Kuwabara; Toshihide Yamashita
Journal:  Nat Med       Date:  2011-03-20       Impact factor: 53.440
  1 in total
  1 in total

Review 1.  Repulsive guidance molecule-a and demyelination: implications for multiple sclerosis.

Authors:  Takekazu Kubo; Shigeru Tokita; Toshihide Yamashita
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-21       Impact factor: 4.147
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.